Literature DB >> 18696085

Referral patterns of patients with liver metastases due to colorectal cancer for resection.

O Al-Sahaf1, Dhafir Al-Azawi, Ammar Al-Khudairy, Mohammad Z Fauzi, Sherif El-Masry, Peter Gilen.   

Abstract

INTRODUCTION: Colorectal carcinoma accounts for 10% of cancer deaths in the Western World, with the liver being the most common site of distant metastases. Resection of liver metastases is the treatment of choice, with a 5-year survival rate of 35%. However, only 5-10% of patients are suitable for resection at presentation. AIMS: To examine the referral pattern of patients with liver metastases to a specialist hepatic unit for resection.
METHODOLOGY: Retrospective review of patient's charts diagnosed with colorectal liver metastases over a 10-year period.
RESULTS: One hundred nine (38 women, 71 men) patients with liver metastases were included, mean age 61 years; 79 and 30 patients had synchronous and metachronus metastases, respectively. Ten criteria for referral were identified; the referral rate was 8.25%, with a resection rate of 0.9%. Forty two percent of the patients had palliative chemotherapy; 42% had symptomatic treatment.
CONCLUSION: This study highlights the advanced stage of colorectal cancer at presentation; in light of modern evidence-based, centre-oriented therapy of liver metastasis, we conclude that criteria of referral for resection should be based on the availability of treatment modalities.

Entities:  

Mesh:

Year:  2008        PMID: 18696085     DOI: 10.1007/s00384-008-0561-6

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  22 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

2.  Improving resectability of hepatic colorectal metastases: expert consensus statement.

Authors:  Eddie K Abdalla; René Adam; Anton J Bilchik; Daniel Jaeck; Jean-Nicolas Vauthey; David Mahvi
Journal:  Ann Surg Oncol       Date:  2006-09-06       Impact factor: 5.344

3.  Proposal for staging liver metastases.

Authors:  L Gennari; R Doci; F Bozzetti; P Bignami
Journal:  Recent Results Cancer Res       Date:  1986

4.  Trends in long-term survival following liver resection for hepatic colorectal metastases.

Authors:  Michael A Choti; James V Sitzmann; Marcelo F Tiburi; Wuthi Sumetchotimetha; Ram Rangsin; Richard D Schulick; Keith D Lillemoe; Charles J Yeo; John L Cameron
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

5.  Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.

Authors:  Timothy M Pawlik; Charles R Scoggins; Daria Zorzi; Eddie K Abdalla; Axel Andres; Cathy Eng; Steven A Curley; Evelyne M Loyer; Andrea Muratore; Gilles Mentha; Lorenzo Capussotti; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

6.  Liver resection for colorectal metastases.

Authors:  Y Fong; A M Cohen; J G Fortner; W E Enker; A D Turnbull; D G Coit; A M Marrero; M Prasad; L H Blumgart; M F Brennan
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

7.  Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history.

Authors:  J Scheele; R Stangl; A Altendorf-Hofmann
Journal:  Br J Surg       Date:  1990-11       Impact factor: 6.939

8.  Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study.

Authors:  Steven R Alberts; William L Horvath; William C Sternfeld; Richard M Goldberg; Michelle R Mahoney; Shaker R Dakhil; Ralph Levitt; Kendrith Rowland; Suresh Nair; Daniel J Sargent; John H Donohue
Journal:  J Clin Oncol       Date:  2005-10-17       Impact factor: 44.544

Review 9.  Review article: Multimodality treatment of liver metastases increases suitability for surgical treatment.

Authors:  K P de Jong
Journal:  Aliment Pharmacol Ther       Date:  2007-12       Impact factor: 8.171

10.  Patient selection for hepatic resection of colorectal metastases.

Authors:  H J Wanebo; Q D Chu; M P Vezeridis; C Soderberg
Journal:  Arch Surg       Date:  1996-03
View more
  2 in total

1.  Treating patients with colon cancer liver metastasis: a nationwide analysis of therapeutic decision making.

Authors:  Hari Nathan; John F Bridges; David P Cosgrove; Luis A Diaz; Daniel A Laheru; Joseph M Herman; Richard D Schulick; Barish H Edil; Christopher L Wolfgang; Michael A Choti; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2012-08-09       Impact factor: 5.344

2.  Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional Evaluation.

Authors:  Julie N Leal; Alexsander K Bressan; Neeta Vachharajani; Mithat Gonen; T Peter Kingham; Michael I D'Angelica; Peter J Allen; Ronald P DeMatteo; Majella B M Doyle; Oliver F Bathe; Paul D Greig; Alice Wei; William C Chapman; Elijah Dixon; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2016-01-30       Impact factor: 6.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.